AI Verdict
HBIO has stronger fundamentals based on our AI analysis.
HBIO vs HAVAR Fundamental Comparison
| Metric | HBIO | HAVAR |
|---|---|---|
| Revenue | $86.6M | N/A |
| Net Income | $-56.7M | $729,121.0 |
| Net Margin | -65.5% | N/A |
| ROE | -412.8% | N/A |
| ROA | -70.8% | 0.5% |
| Current Ratio | 2.20x | 2.34x |
| Debt/Equity | 2.61x | N/A |
| EPS | $-1.28 | $-0.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HBIO vs HAVAR: Frequently Asked Questions
Is HBIO or HAVAR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HBIO has stronger fundamentals. HBIO is rated STRONG SELL (92% confidence) while HAVAR is rated STRONG SELL (85% confidence). This is not investment advice.
How does HBIO compare to HAVAR fundamentally?
HARVARD BIOSCIENCE INC has ROE of -412.8% vs Harvard Ave Acquisition Corp's N/A. Net margins are -65.5% vs N/A respectively.
Which stock pays higher dividends, HBIO or HAVAR?
HBIO has a dividend yield of N/A or no dividend while HAVAR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HBIO or HAVAR for long term?
For long-term investing, consider that HBIO has STRONG SELL rating with 92% confidence, while HAVAR has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HBIO vs HAVAR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HBIO vs HAVAR, the AI consensus favors HBIO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.